Additional file 6 of Evaluating the national system for rare diseases in China from the point of drug access: progress and challenges

Additional file 6: Table S6. The median unit prices of generic orphan drugs surveyed in 30 leading provincial institutions in China from 2017-2020 (USD).附加文件6：附表S6。2017至2020年中国30家省级领军医疗机构调研的仿制药孤儿药（generic orphan drugs）中位单价（以美元计价）。